NCBI Summary
This gene encodes the carbohydrate-binding protein malectin which is a Type I membrane-anchored endoplasmic reticulum protein. This protein has an affinity for Glc2Man9GlcNAc2 (G2M9) N-glycans and is involved in regulating glycosylation in the endoplasmic reticulum. This protein has also been shown to interact with ribophorin I and may be involved in the directing the degradation of misfolded proteins. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015].
Protein
Protein (NP_055545)
Malectin
Malectin
MLEC
malectin
Undefined
Curated
Malectin
Undefined
b-sandwich / ConA-like
Glc(2)Man(9)GlcNAc(2)
0.925
Protein sequence and protein families (fasta) (292 amino acids) Download
MLGAWAVEGTAVALLRLLLLLLPPAIRGPGLGVAGVAGAAGAGLPESVIWAVNAGGEAHVDVHGIHFRKDPLEGRVGRASDYGMKLPILRSNPEDQILYQTERYNEETFGYEVPIKEEGDYVLVLKFAEVYFAQSQQKVFDVRLNGHVVVKDLDIFDRVGHSTAHDEIIPMSIRKGKLSVQGEVSTFTGKLYIEFVKGYYDNPKVCALYIMAGTVDDVPKLQPHPGLEKKEEEEEEEEYDEGSNLKKQTNKNRVQSGPRTPNPYASDNSSLMFPILVAFGVFIPTLFCLCRL
Mol* PDB structure viewer

Either no PDB or existing PDB of non-glycosylated form

Structural models
Model Confidence:
  •    Very high (pLDDT > 90)
  •    Confident (90 > pLDDT > 70)
  •    Low (70 > pLDDT > 50)
  •    Very low (pLDDT < 50)

  AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Some regions with low pLDDT may be unstructured in isolation.

SWISS-MODEL structural models
Ligand
Glycan ligands from structural data
No crystal structures of complexes with glycan ligand.
References
NCBI References (10 PubMed Identifiers)
  • Cryo-electron microscopy structures of human oligosaccharyltransferase complexes OST-A and OST-B. [31831667]
  • Histone Interaction Landscapes Visualized by Crosslinking Mass Spectrometry in Intact Cell Nuclei. [30021884]
  • Malectin gene polymorphisms promote cerebral palsy via M2-like macrophage polarization. [28972276]
  • Association of malectin with ribophorin I is crucial for attenuation of misfolded glycoprotein secretion. [25451265]
  • Malectin forms a complex with ribophorin I for enhanced association with misfolded glycoproteins. [22988243]
  • Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of alpha1-antitrypsin. [21813736]
  • MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia. [20347265]
  • Malectin: a novel carbohydrate-binding protein of the endoplasmic reticulum and a candidate player in the early steps of protein N-glycosylation. [18524852]
  • Getting in and out from calnexin/calreticulin cycles. [18303019]
  • The heterodimeric structure of glucosidase II is required for its activity, solubility, and localization in vivo. [10929008]
UniProt Main References (5 PubMed Identifiers)
  • Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1. [8590280]
  • The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). [15489334]
  • Initial characterization of the human central proteome. [21269460]
  • An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. [24275569]
  • N-terminome analysis of the human mitochondrial proteome. [25944712]
All isoforms of this gene containing a lectin domain
NP_055545.1, NP_001290556.1, XP_011537333.1, XP_011537334.1, NP_001290557.1
RNA
RNA (Transcript ID: NM_014730.4)
malectin, transcript variant 1
m7G-5')ppp(5'-GUGGCUGAGAAGAAGGAGGCCUGAGAGCGACAUGUCCCCGGCGGCUCAGGCGGAGCGGCCCGUGGCGCUGUUUUUCUGAGUCCGGGGUGGCCUGGCAGCCGGCCGAGGACGAGGGUCGGCGGGGGCUGCCCCCGUGGUGGUGGCCGCCAUGCUGGGAGCCUGGGCGGUUGAGGGAACCGCUGUGGCGCUCCUGCGACUGCUGCUGCUGCUGCUGCCGCCGGCGAUCCGGGGACCCGGGCUCGGCGUGGCCGGCGUGGCCGGCGCGGCGGGGGCCGGGCUGCCCGAGAGCGUCAUUUGGGCGGUCAACGCGGGUGGAGAGGCGCAUGUGGACGUGCACGGGAUCCACUUCCGCAAGGACCCUUUGGAAGGCCGGGUGGGCCGAGCCUCAGACUAUGGCAUGAAACUGCCAAUCCUGCGUUCCAACCCUGAGGACCAGAUCCUGUAUCAAACUGAGCGGUACAAUGAGGAGACCUUUGGCUACGAAGUGCCCAUCAAAGAGGAGGGGGACUACGUGCUGGUCUUGAAAUUUGCAGAGGUCUACUUUGCACAGUCCCAGCAAAAGGUAUUUGAUGUACGAUUGAAUGGCCACGUCGUGGUGAAGGACUUGGAUAUCUUUGAUCGUGUUGGGCAUAGCACAGCUCACGAUGAAAUUAUACCUAUGAGCAUCAGAAAGGGGAAGCUGAGUGUCCAGGGGGAGGUGUCCACCUUCACAGGGAAACUCUACAUUGAGUUUGUCAAGGGGUACUAUGACAAUCCCAAGGUCUGUGCACUCUACAUCAUGGCUGGGACAGUGGAUGAUGUACCAAAGCUUCAGCCUCAUCCGGGAUUGGAGAAGAAAGAAGAGGAAGAAGAAGAAGAAGAAUAUGAUGAAGGGUCUAAUCUCAAAAAACAGACCAAUAAGAACCGGGUGCAGUCAGGCCCCCGCACACCCAACCCCUAUGCCUCGGACAACAGCAGCCUCAUGUUUCCCAUCCUGGUGGCCUUCGGAGUCUUCAUUCCAACCCUCUUCUGCCUCUGCCGGUUGUGAGAACAAAUGACUAUCCUGAACAGGGUGGAGGGGUGUGGGAAAGAAACCAGCCAUAUUGGUUUUGGUUUCUGUAUUUUUCACAAUGAUUAAUGAACAAAAACAAAGAGAAAAAAACACACAUCAAUUAAAGGAGACAAAAAGAGGCAGAGCGAGUAGAGAGCAGCCCUCAUUCACCACCUGGUCCCAGACGUGCUUCAGUCCUCGUCCUCUCUUUGUGGCUGGCUCCCAGCCUUCUCUUUCCUCUUGAGGAUACUUAGGGUAAACUGGAUCCUUCCUGCUCAAGGAUCCUCAUUUGUAUACCUAGUGGAAAGGACUCUGAACUCAGAGGAGUCACUGUUCCUUUUUUUAGGUUAGAAAUUAACAGCAGGGAAAUGCCAUCUUAUUACCUGAGACGACCAGCACUGGGAGUUAGGUACGGUCUGAAGUUAUGUCUAGAUAAGACUUCAGACGUCCUGGGAUUGAAAGAAUGUGUGUGAAGGGGUAGAAUUUGUGCGGUAAAGACUUAAAAAAAAAAGUAGGGAGAUUAAAAAAAAAGAAAGAAAAUGCUUCCUUAUCUGGAAGCCUUUCUGGAUUAAUCCAGUGAUGGUCCCACCUUUAGUGUUUGAGCUUUGUCAUUGCUUGUCUCCCUGGCAUGUGCCAGUUAUAGACUGUCCAGCAUCCAAGACGUUUCGGUUAUGUCGGGUCCUCAGAUCGCCUCUGACUUGUUACCACAACAAAUCAUUUUGAUUUCAGUGCCUGUUGGGGACUUGAUUUCUUCUCAGUUUUGUUUGUUUGUUUGUUUCCUUAAUCUGGCUCAUUUGAAAUUUCUUCUCCCUCUCAACCAUCCCACUAAGUUAUAGCCAAGAAGGGAAGGAGACACGGGGAUUUGGGGUUCUCUGCUUGAAUGUCUUCUCCUUUACCACCUCACCUUGUUGGUACCUCCCUCCCUGGAUCUCUGAGCCAGCAGCCAGGAGGACCUGACCCAGCAGUUCUUUACUGGCCCCUUUGUAGGGCCUUGCUGCCAGGGGGCAGGGAUGCUUUCCAGCCUGCAGCAACAGAACACUUGACCUUAAAAGUCUCUUCUGGUCUUUGGAUUAGAAAAGGCUUAUGUUAGCAUAGCUUAAGAGCAACCUCAGAGAUUUGAGCCCUACUAAGUGACUGACCACUGUUUAGAGUGUCUGGUAUCUGAUGUUCAUUUAUUCCCAUGUUCUUGUGUGUCACAGUUCAGCCAGUUUUGGUUUAUGCCUAGAGCUACUUCAAGGAACUAGACUAAUUAGCUAUAUAGGCCCAGCGAUGCUUCUUAUUGAUCUUAAUAGUAUGCCCCUCCUUCCCCUGUCCUUUCAUUUCUCUAUCCAAGUAGCAGUCAGGUUCUUGGUGUGAUGGGACUGAAAGAAUUCCAGUCAGCCAGAGCCUUGGCAGCUCUGAAGCUAACCUUAGCAUCUAAGUGUCGAUCUUGAAUUCCCUGAAAAAAUUUCUAUAGGAAAUGAAGCUUCCCUGGUCCCCUCCUUUCUGGCCAUUGUCAUCCAUUUCCCAGUUAGGGCAACAAUGAAGGAGGACCCAGCCAAGCUAGAAGGAAUUUUGUGGAUGGGAGACAGCAGGAUUAGCUUCAGCUUGGGCUGGAGCAGUCAAUAUAGGAUCUCAGGCCAGGCCCGCUUUUCUAGAAUGUGUUUAAUUUUGAGUUUGCUUUAUUAGAUAUGUUUUUUAAGAGCUCUGUAUAUUUGAACUGCUCCUUAUGUGACAAAAUAGGUAGCUCUUGGGCUCAUGUCCUGGGUUUUGGCUCUUUAAUGAUUACUCCAGGCCAGCAUUUAGUCGUUUGAGAAUUGUAGCCUGUUGUUUUCGCUGUGACUUGGGUCUCAGUGCUAGGGUAUUGAGUCAGGCAGCUGGAGGGUUGUGGCCCGAGGCUGCAGUCAGAGGUAUACUUCCCAUAGUGCUUCACACAGCUCCCCUGCUUCUAAAGGAUAAGGUACUGUAGCCUUGGUCCUGGGGACCACCUGCCUGGGGCAGUGGACAUCCUAACUAAACAGGCUUCUGGCAGUAGCUUUGGUUCCUAUCCCAUCGAAAUUCCCCAAAGCCCUGGGCCACUGCCAUUGGGUUAGUCAAGAUGAAGGAGGAGGACUGGCUGCCUCCAUUUUGCCUUGUUUGUUAGUUUGCCUGGGUCUGUCUGAGGAAGGAGGGGGUCCCGCCUUCCACCUCAACACAUCCCUUCAGUGACUCAGAGUCUCAGAAGGAAACCCUGACUCCUGGGGCCAUUUCCUAAUGGUACUGUAAGCCAAGCAGCUUUGCUUCUGCCUCUGUUUCCAAGCCCACCCUUUUCCCCUGAGCUCAGGGUUAGGGAUGGGCGCUUUCCUCUCUGGUUGUGAACGAAAGGAAGGAACAUCUUUCUAUGGCUAACAAAAACUAAAGGGGAAGUGAGGAAACAGGAAGAAGUAUGGUGGGGGCUGGGGUAGACUCCCCUGGAGCCAAGCCUAUCCAGCUAACAAGAGCUCCCUGGGGCUGGUCACAGCUGGCUCAUGAUGCUGAACUUGAAAGUUUUUUUGUUUUUGUUUUUGUUUUGUGGCUCCUCCAAGAUAUAGGUACAUGAAGUUUAGGUUAAAGGGGUGGGAUUCUUUAUUUUUAUUUUUGUAUUGUAUGUGUCAAGAAUUACUCUGUUGUUCACCUUUUGCUUUUUGCACUGUUUGUUCUCUUAUCUGUAUUUUGAGCUUAGUGCUAGGACUGAGAGGCUGCACCAUAGGGAAUGUAUGGGAGAUGGUGAGGGGUGCCAGUGAGGGGUGCGUGGAGGAGAGGCCUGGGCUCCUCUACUGGAUCUACACUCUGUCCCAGGUUUUUAGAUCCCACUGAGCCCAGCUGACUGAAAACAAGGACAGUCAGGGUGAAACUUCUUUUGCCAGAAGUGUGGCCUGAGUUGAAUUUCUGGGAGGAUGACGCAGAUGUCUGCUGCAGAGCUGGGCUGAGAGUUCUGCAGUCUAGCUCUGACUUAGGUCAGGGGCCUGUUGGUCUCUCAUUGGACGUUUUUGGGUCUCACUCAUGCUUACUGAAACAUUGUGCCAAGAAACUCUGUGGGAUUUGUGUCCCUUAAACCAGACUCACUUUUCUGAAAAAUCUCCAUUGUUGAGGAGAGGCUGCUCAAUCGACACCCCGAGUUCUCAUGACUGGGAAGAUAGUUUUCUUCAGGUGUCAAUGGCGUUAGACUCCCAGGAAGACUAGCCCUGCCCACAGGGCCACCUGUUGGUUUGAGAGCGUGUUCGUGUUCUCUUGCCCUCCCUGCCUAAGAGCUACUGGGAUCACGUUAGCGGGCAUUUAGGCUUUGAUGAGAGGGCACAGUUUGAGUUAGGUUUACCUCCCCCUUUCUGUGCCUGGGAACUGUUUGGUCCAGCUUUAGAACUGUGGUUUUGACUUCCUUAUCUCUUGGGAGAAGCUUCUGUUUUAAGGAAUUUCUCUUCCUUCUUCUCCUGCCUCUAGCCUCUCCUGGAAAGGCCUGGAUAUGGUUUCUAAAAUCUCAGCUGAGAACUUCAGAAAACAGCAGCAGUAUUUUCCUUUUCCUAGUGCUAAAAUCCCUUUCCCUAGAAAUUGGCUCACCUUGGGAAACCCAGGGAAAGAAUCAGCAGGUUCUCUGCCCUCCCUAGGGGUUGGGGAAGGACCCACCCCGGUCAGCACAGUGCCUUUUCCUCUCCUGCUCUGAGCCAGGGUGGGGCAUUCCCUCUAGAUUCAGGUUUGGGCAGGGGUCCUAUAGUCCCUGCCAUGGGGCUGCUUCCCUGUCCCUUCCCUCCCCUUUGCUGGCCUACUCUGGCAUAAUUCAAGUGUCUUCUUGCCUUGGGGAUCCUUAGUGGCAUCAAAUGGCAACAUGGAAUAUUGUCCUCCAUGCCCCUCCAGAAGGACCUAGGAGAGUAGGUGAGCUUUCCAAAGUGAGAGACGAAUCUUUCUUUCUUUUUUUUUUUAAAGGGCAGGAUGGGUAUGCUUUGGGCUUUCUCCUUCUGUGGCCCCGGAGGAAGGAGAGACUGAGGCAAGGCAAAGUGAUAGUACACGGAAGCAGAACCGGAAACACCCAGGAACUGUUCAGAAAUCUCAGAAGAAAUCUGCUUCUCUUCGAUGGAAAGAUAUAAUUAACGAUCAAAGAGCUCUAAGAAAAUUGCAAAGAAGCCUUAAUGUUCAAGCUUUAGAAAGAUCAGAGCAAUUUUUCUCUUUCAGUCCAAACUAAGACUCUCUGUAUUUAAAUCUCUCUGGGGCAAGAGGGCUAGAUUUCCUCAUUUUGUUAUGAGACUAGAUUGGUACCAGUAGAUCAGCUGCCUAGCGAGGGCAGGUUUCUUCUUUGCAUCUGUGUGGCUUGCUUCCAGUCUGGCCUGUCCUUUCCAGCUGCCUUUUGUCUAGCCUGCUAUGGGGGGCCAGAUUAUCUUGAUAAGAGCAGGUGAUUUGGGGACUAGCUGGGUUGGCAGGAAAAGAGCAGGAUGGAUCUCUUGGGACAGGUUCCCCCAGGAGUAUAAACACAAGGAGCCAGGAUUGUGCUGGCAGCCAAGGAAACAGUAGUGCCUGUUUGAGUUGGCAGAGAGGGCCUUGGCACCUCUUGCAUCCAGGCAGUCUUGUGAGAUGGGGGCACAUAGCACUGGGGAAAGCAGAACUCCAUUCUCACCUCUAUUUUGAGCUUCAGUGCUUUAUUUCAGUAUGAGGAAAAACAACAACAAACUGAAGUGCGCUUUCCGUCCUUUCAAAGGACAACUGUCGGGAAGGGAGAGCCGAGUUGCGAGGUAGGAGGGGAGCACUGGCAGGGAGAGACAUUCUUGACUCCUCUCUUCCCUGGUGUGUUGUGAUCCAGGGAAUGAAAAGAAAUUUGACCCUGGAUUGGUUCUCUCCUUGGACUUAAGGAAUCUUACCUUUUCCUUCCACAAAGUUCUCCCAGGCAAGGACCAGCUGCCCAUUCUGAGCCCAGGGCAGCCUCUUCAACCAUUAUUGGUCUAACCUGGCUUGUCAGGAAACCAAGCCCACCCUUCCACAUUGGGCCUGGCUGCUCUAUUCUGUACCAAGUACUGGAGAAAAAGCAUCAAGUUCUUAGCCCUUGUAGCUUCUACCCUAGUUUCCCAUCCUCUCUCUGUGGAGGCCAAACCAACUCUUUGCCAGCAGCCACAACAUGCAUUGACAGCGGCACAGUGAGAUAUAACUGAUGGGCUUUGAACCUGGUUGGCCGGGGAAGCUGUAGGGGUGGAUAGAGCUGGCUUUCCUUCUGGGCUGUCUCCAUCUGACCCUACCCCUUCCAUGUCCCACCCCACUCCCACCAAAAAGUACAAAAUCAGGAUGUUUUUCACUGUCCAUUGCUUUGUGUUUUAAUAAACAAUUUGCAGUGACA-3'- Poly-A tail
  • Coding region
;
DNA
DNA (Gene ID: 9761)
malectin
strand +
NCBI CDS gene sequence (879 bp)
5'-ATGCTGGGAGCCTGGGCGGTTGAGGGAACCGCTGTGGCGCTCCTGCGACTGCTGCTGCTGCTGCTGCCGCCGGCGATCCGGGGACCCGGGCTCGGCGTGGCCGGCGTGGCCGGCGCGGCGGGGGCCGGGCTGCCCGAGAGCGTCATTTGGGCGGTCAACGCGGGTGGAGAGGCGCATGTGGACGTGCACGGGATCCACTTCCGCAAGGACCCTTTGGAAGGCCGGGTGGGCCGAGCCTCAGACTATGGCATGAAACTGCCAATCCTGCGTTCCAACCCTGAGGACCAGATCCTGTATCAAACTGAGCGGTACAATGAGGAGACCTTTGGCTACGAAGTGCCCATCAAAGAGGAGGGGGACTACGTGCTGGTCTTGAAATTTGCAGAGGTCTACTTTGCACAGTCCCAGCAAAAGGTATTTGATGTACGATTGAATGGCCACGTCGTGGTGAAGGACTTGGATATCTTTGATCGTGTTGGGCATAGCACAGCTCACGATGAAATTATACCTATGAGCATCAGAAAGGGGAAGCTGAGTGTCCAGGGGGAGGTGTCCACCTTCACAGGGAAACTCTACATTGAGTTTGTCAAGGGGTACTATGACAATCCCAAGGTCTGTGCACTCTACATCATGGCTGGGACAGTGGATGATGTACCAAAGCTTCAGCCTCATCCGGGATTGGAGAAGAAAGAAGAGGAAGAAGAAGAAGAAGAATATGATGAAGGGTCTAATCTCAAAAAACAGACCAATAAGAACCGGGTGCAGTCAGGCCCCCGCACACCCAACCCCTATGCCTCGGACAACAGCAGCCTCATGTTTCCCATCCTGGTGGCCTTCGGAGTCTTCATTCCAACCCTCTTCTGCCTCTGCCGGTTGTGA-3'
NCBI CDS gene sequence with introns (location: 120687297.. 120696545) (9249 bp)Download
NCBI CDS gene sequence with introns, 5'UTR and 3'UTR (location: 120687149.. 120701859) (14711 bp)Download
NCBI gene sequence (location: [120687149 - 1000].. 120701859) (15711 bp)Download
Cite How to cite